Global Vascular Graft Market

Vascular Graft market was valued at USD 2.24 Bn in 2025 is expected to reach USD 3.62 Bn by the end of 2032 at a CAGR of 7.1% from 2o26 to 2032.

Vascular bypass graft surgery involves bypassing a blocked or narrowed artery in order to restore proper blood flow to vital organs such as the heart or brain, or to extremities, most commonly the legs. The procedure is commonly performed in patients suffering from severe coronary artery disease, peripheral artery disease, and other cardiovascular complications. Depending on the location and severity of the blockage, different types of vascular bypass graft surgeries are performed, and these procedures are typically considered major surgeries that require significant post-operative recovery and monitoring.

According to the British Heart Foundation, around 2.3 million people in the United Kingdom are currently living with coronary heart disease, and the condition accounts for approximately 70,000 deaths annually in the country. The increasing prevalence of cardiovascular diseases (CVDs), along with the rising geriatric population and growing incidence of lifestyle-related disorders such as diabetes and hypertension, has significantly increased the demand for vascular graft procedures worldwide. As a result, the adoption of vascular grafts for the treatment of cardiovascular disorders is increasing across healthcare systems.Thus, from 2025 to 2032, the Vascular Graft Market is expected to witness steady growth driven by the rising burden of cardiovascular diseases, increasing number of vascular surgeries, and continuous advancements in graft materials and minimally invasive surgical technologies.

To know about the Research Methodology :- Request Free Sample Report

Vascular Graft Market Segment Analysis

By Product Type

Based on Product Type, the Endovascular Stent Grafts segment held the largest market share in the Vascular Graft Market in 2025. Endovascular stent grafts are widely used in minimally invasive procedures for the treatment of abdominal aortic aneurysms and other vascular diseases. These grafts are preferred due to their ability to reduce surgical trauma, shorten hospital stays, and improve patient recovery compared to traditional open surgeries. Increasing adoption of minimally invasive vascular procedures, along with technological advancements in stent graft materials and designs, is expected to drive the growth of this segment during the forecast period.

By Raw Material

Based on Raw Material, the Expanded Polytetrafluoroethylene (ePTFE) segment dominated the Vascular Graft Market in 2025. ePTFE grafts are widely used in vascular surgeries due to their superior biocompatibility, flexibility, and durability. These grafts provide excellent resistance to thrombosis and are commonly used in haemodialysis access grafts and peripheral vascular graft procedures. Increasing demand for long-lasting and reliable graft materials in cardiovascular surgeries is expected to further boost the growth of this segment over the forecast period.

By End User

Based on End User, the Hospitals segment held the largest share of the Vascular Graft Market in 2025. Hospitals are the primary centers where vascular surgeries and complex cardiovascular procedures are performed. The increasing number of cardiovascular surgeries, improved healthcare infrastructure, and the availability of advanced surgical technologies in hospitals are contributing significantly to the growth of this segment. In addition, the rising prevalence of cardiovascular diseases and increasing hospital admissions for vascular procedures are expected to drive the demand for vascular grafts in hospitals during the forecast period.

Vascular Graft Market Regional Analysis

Region-wise, North America dominated the Vascular Graft Market in 2025 and is expected to maintain its leading position during the forecast period. The region is a major contributor to the market due to the high prevalence of cardiovascular diseases, well-established healthcare infrastructure, and increasing adoption of advanced medical technologies. The United States holds the largest share in North America due to the presence of major medical device manufacturers, high healthcare expenditure, and a growing number of vascular surgeries performed each year. Additionally, favourable reimbursement policies and increasing awareness about early diagnosis and treatment of cardiovascular diseases are expected to further support market growth in the region.

Asia Pacific is expected to witness the fastest growth during the forecast period. The increasing prevalence of cardiovascular diseases, rapidly improving healthcare infrastructure, and rising healthcare expenditure in countries such as China and India are major factors driving market growth in this region. Additionally, the growing geriatric population and increasing demand for advanced cardiovascular treatments are expected to accelerate the adoption of vascular graft procedures across Asia Pacific.

Recent Industry Developments (2025–2026)

Vascular Graft Market Scope: Inquire before buying

Vascular Graft Market, by Region

North America(United States, Canada, Mexico)
Europe(UK, France, Germany, Italy, Spain, Sweden, Austria, Rest of Europe)
Asia Pacific(China, Japan, South Korea, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan, Rest of Asia Pacific)
Middle East & Africa(South Africa, GCC, Egypt, Nigeria, Rest of Middle East & Africa)
South America(Brazil, Argentina, Colombia and Rest of South America)

Vascular Graft Market Key Players

1. Medtronic plc
2. W. L. Gore & Associates Inc.
3. Becton Dickinson and Company
4.  B. Braun Melsungen AG
5. Terumo Corporation
6. Getinge AB
7. LeMaitre Vascular Inc.
8. Cook Medical Inc.
9. Endologix LLC
10. Cardinal Health Inc.
11. CryoLife Inc.
12. Abbott Laboratories
13. Boston Scientific Corporation
14. Meril Life Sciences Pvt. Ltd.
15. Vascutek Ltd.
16. Jotec GmbH
17. Maquet Holding B.V. & Co. KG
18. Lombard Medical Technologies PLC
19. MicroPort Scientific Corporation
20. Endospan Ltd.
21. Vascular Concepts Limited
22. Braile Biomédica
23. C. R. Bard Inc.
24. Artivion Inc.
25. Edwards Lifesciences Corporation
26. Biotronik SE & Co. KG